HHS Alert Is Pharma's Guide To Mitigating Anti-Kickback Risk
For years the U.S. Department of Justice and the U.S. Department of Health and Human Services have pursued enforcement cases alleging inducement schemes through medical device and pharmaceutical company programs that...To view the full article, register now.
Already a subscriber? Click here to view full article